Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia.
Medical School, University of Zagreb, Croatia.
Dino
D
Dujmovic
Igor
I
Aurer
Ivo
I
Radman
Ranka
R
Serventi-Seiwerth
Snjezana
S
Dotlic
Ranka
R
Stern-Padovan
Klara
K
Dubravcic
Fedor
F
Santek
Boris
B
Labar
D000293:Adolescent; D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D024221:Antineoplastic Protocols; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage*; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D008727:Methotrexate